Experimental Coronavirus Drug
- All
- News
- Videos
-
Covid Pill Shows Rapid Clearance Of Virus, Says Japan Pharma Firm
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
-
Pfizer Says Its Antiviral Pill Cuts Risk Of Severe Covid By 89%
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease.
-
Why Merck's Covid Pill Is Seen As Such A Breakthrough
As Merck & Co. races ahead with an experimental pill that could play a pivotal role in the fight against Covid-19, efforts are intensifying to bring the drug to developing countries that have struggled to vaccinate their populations.
-
UK To Roll Out Life-Saving Covid Drug Given To Donald Trump
The treatment was used as part of the suite of experimental medicines given to Trump when he tested positive for COVID-19 last year.
-
"Not Life-Saving Drug": Centre Clarifies On Remdesivir
Antiviral drug Remdesivir is not a life-saving drug and its "unnecessary or irrational" use on Covid patients is unethical, the centre tweeted on Monday, amid massive demand for the medicine triggered by an unprecedented surge in coronavirus cases.
-
US Allows Emergency Use Of First COVID-19 Antibody Drug
U.S. regulators on Monday authorized emergency use of the first experimental antibody drug for COVID-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions.
-
Gilead Seeks US Approval For Drug That Shortens Covid Recovery Time
Gilead Sciences Inc has filed an application with the U.S. Food and Drug Administration seeking full approval for remdesivir, its experimental COVID-19 drug currently used under emergency authorization, the drugmaker said on Monday.
-
US Makes Deal For 100 Million Doses Of COVID-19 Vaccine, Deaths Expected To Rise
Two major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine, the Trump administration said on Friday, as the nation's top health agency predicted that fatalities would rise in the coming weeks.
-
Maharashtra Stocks Up COVID Drug Remdesivir Amid Black Marketing Reports
Maharashtra has placed orders for the procurement of life-saving experimental COVID-19 medicines, including Remdesivir and Tocilizumab, to halt black marketing of the drugs amid a steady rise of coronavirus cases.
-
Maharashtra, Delhi Among 5 States To Receive First Batch Of COVID-19 Drug
Hyderabad-based drugmaker Hetero, which has approval to manufacture and market the generic version of the experimental COVID-19 drug Remdesivir, has sent 20,000 vials to five states including Maharashtra and Delhi - the two worst affected states in the country.
-
Health Ministry Drafts Rules To Help Coronavirus Patients Access New Drugs
Seeking to facilitate the availability of experimental drugs for severely-ill COVID-19 patients, the Union Health Ministry has issued a draft notification for "compassionate use" of any unapproved drug that is in the phase-III clinical trial globally.
-
Promising COVID-19 Vaccine Sends Drug Firm's Shares Soaring
Moderna Inc said on Monday its experimental COVID-19 vaccine showed promise in a small early-stage trial, with the vaccine producing virus-neutralizing antibodies similar to that found in recovered patients, sending shares soaring 25%.
-
India's Jubilant Signs Licensing Deal For US Pharma Firm Gilead's COVID-19 Drug
India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries, including India.
-
Gilead Says In Talks With Drugmakers In India, Pak For Making Remdesivir
Gilead Sciences Inc said on Tuesday it was in discussions with chemical and drug manufacturers to produce its experimental COVID-19 drug remdesivir for Europe, Asia and the developing world through at least 2022.
-
US Issues Emergency Approval For Remdesivir For COVID-19 Patients
The experimental drug remdesivir has been authorized by US regulators for emergency use against COVID-19, President Donald Trump announced Friday.
-
Covid Pill Shows Rapid Clearance Of Virus, Says Japan Pharma Firm
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
-
Pfizer Says Its Antiviral Pill Cuts Risk Of Severe Covid By 89%
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease.
-
Why Merck's Covid Pill Is Seen As Such A Breakthrough
As Merck & Co. races ahead with an experimental pill that could play a pivotal role in the fight against Covid-19, efforts are intensifying to bring the drug to developing countries that have struggled to vaccinate their populations.
-
UK To Roll Out Life-Saving Covid Drug Given To Donald Trump
The treatment was used as part of the suite of experimental medicines given to Trump when he tested positive for COVID-19 last year.
-
"Not Life-Saving Drug": Centre Clarifies On Remdesivir
Antiviral drug Remdesivir is not a life-saving drug and its "unnecessary or irrational" use on Covid patients is unethical, the centre tweeted on Monday, amid massive demand for the medicine triggered by an unprecedented surge in coronavirus cases.
-
US Allows Emergency Use Of First COVID-19 Antibody Drug
U.S. regulators on Monday authorized emergency use of the first experimental antibody drug for COVID-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions.
-
Gilead Seeks US Approval For Drug That Shortens Covid Recovery Time
Gilead Sciences Inc has filed an application with the U.S. Food and Drug Administration seeking full approval for remdesivir, its experimental COVID-19 drug currently used under emergency authorization, the drugmaker said on Monday.
-
US Makes Deal For 100 Million Doses Of COVID-19 Vaccine, Deaths Expected To Rise
Two major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine, the Trump administration said on Friday, as the nation's top health agency predicted that fatalities would rise in the coming weeks.
-
Maharashtra Stocks Up COVID Drug Remdesivir Amid Black Marketing Reports
Maharashtra has placed orders for the procurement of life-saving experimental COVID-19 medicines, including Remdesivir and Tocilizumab, to halt black marketing of the drugs amid a steady rise of coronavirus cases.
-
Maharashtra, Delhi Among 5 States To Receive First Batch Of COVID-19 Drug
Hyderabad-based drugmaker Hetero, which has approval to manufacture and market the generic version of the experimental COVID-19 drug Remdesivir, has sent 20,000 vials to five states including Maharashtra and Delhi - the two worst affected states in the country.
-
Health Ministry Drafts Rules To Help Coronavirus Patients Access New Drugs
Seeking to facilitate the availability of experimental drugs for severely-ill COVID-19 patients, the Union Health Ministry has issued a draft notification for "compassionate use" of any unapproved drug that is in the phase-III clinical trial globally.
-
Promising COVID-19 Vaccine Sends Drug Firm's Shares Soaring
Moderna Inc said on Monday its experimental COVID-19 vaccine showed promise in a small early-stage trial, with the vaccine producing virus-neutralizing antibodies similar to that found in recovered patients, sending shares soaring 25%.
-
India's Jubilant Signs Licensing Deal For US Pharma Firm Gilead's COVID-19 Drug
India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries, including India.
-
Gilead Says In Talks With Drugmakers In India, Pak For Making Remdesivir
Gilead Sciences Inc said on Tuesday it was in discussions with chemical and drug manufacturers to produce its experimental COVID-19 drug remdesivir for Europe, Asia and the developing world through at least 2022.
-
US Issues Emergency Approval For Remdesivir For COVID-19 Patients
The experimental drug remdesivir has been authorized by US regulators for emergency use against COVID-19, President Donald Trump announced Friday.
